\documentclass[10pt]{article}

\input{report/inc/preamble.tex}

\addbibresource{report/biblio.bib}

\begin{document}

\maketitle

\begin{abstract}
\noindent
\begin{abstractdesc}
\item[Background] TODO
%
\item[Methods] TODO
%
\item[Results] TODO
%
\item[Conclusions] TODO
\end{abstractdesc}
\end{abstract}

\tableofcontents


\section{Background}

The establishment of the clinical trial submission requirements in
Section 801 of the Food and Drug Administration Amendments Act of 2007
(FDAAA 801)~\cite{publiclaw_fdaa_2007_s801}
mandated that any applicable clinical trials (ACTs) must
submit their summary results to the \ctgov{} data bank one year from study completion.
This regulation went into effect on \ISOtoLocaleDisplayDate{2017-01-18}
and compliance was required starting 90 days later on
\ISOtoLocaleDisplayDate{2017-04-18} for all responsible
parties~\cite{ctgov_fdaaa801_final_rule_2024,zarin_trial_2016}.

\section{Methods}

\textcite{anderson_compliance_2015} present an algorithm to
determine which trials are likely to be ACTs which they term as
highly likely applicable clinical trials (HLACTs).

To ensure that similar methods are used, the replicated HLACTs
algorithm is compared against the \textcite{anderson_compliance_2015}
shared dataset~\cite{anderson_data_20130927}.

\section{Results}


\begin{figure}
	\includegraphics[width=0.95\textwidth]{figtab/rule-effective/fig.result_reported_within.facet_overall.stacked_area.png}
	\label{fig:results-reported-rule-effective-overall}
	\caption{Results before and after the effective rule date (overall)}
\end{figure}

\begin{figure}
	\includegraphics[width=0.95\textwidth]{figtab/rule-effective/fig.result_reported_within.facet_funding.stacked_area.png}
	\label{fig:results-reported-rule-effective-funding}
	\caption{Results before and after the effective rule date by funding source}
\end{figure}


\section{Discussion}

\printbibliography

\end{document}
